Sökresultat

Filtyp

Din sökning på "*" gav 550122 sökträffar

New research paves way for developing therapies that could slow down Alzheimer´s

Neuroscientists and stem cell researchers at Lund University in Sweden have developed a research model that allows studying human hippocampal neurons, the brain cells primarily affected by Alzheimer’s disease pathology. The study has been published in Stem Cell Reports.Read the full article here.See also interview with Alzheimerfonden regarding the study. 

https://www.multipark.lu.se/article/new-research-paves-way-developing-therapies-could-slow-down-alzheimers - 2025-12-15

New blood test shows great promise in the diagnosis of Alzheimer’s disease

A new blood test demonstrated remarkable promise in discriminating between persons with and without Alzheimer’s disease and in persons at known genetic risk may be able to detect the disease as early as 20 years before the onset of cognitive impairment, according to a large international study published today in the Journal of the American Medical Association (JAMA) and simultaneously presented at

https://www.multipark.lu.se/article/new-blood-test-shows-great-promise-diagnosis-alzheimers-disease - 2025-12-15

Millions from Michael J. Fox Foundation to improve diagnosis of Parkinson's

Around 20,000 people have been diagnosed with Parkinson's disease in Sweden. Today, there is no imaging method of changes in the brain that are believed to cause the disease. Researchers at Skåne University Hospital and Lund University have received nearly SEK 7 million from the Michael J Fox Foundation to develop an imaging technique that can more accurately detect and track the development of Pa

https://www.multipark.lu.se/article/millions-michael-j-fox-foundation-improve-diagnosis-parkinsons - 2025-12-15

Of Four Aβ Antibodies, Only Aducanumab Stems Tide of Toxic Oligomers

Aducanumab was compared, in a blinded study, to three clinical-stage antibodies using chemical kinetics. The publication describes the use of chemical kinetic analysis to assess the mechanisms of action of four clinical stage anti-Aβ antibodies: aducanumab (Biogen), gantenerumab (Roche), bapineuzumab (Elan) and solanezumab (Eli Lilly). The results provide unique insights into potential correlation

https://www.multipark.lu.se/article/four-ab-antibodies-only-aducanumab-stems-tide-toxic-oligomers - 2025-12-15

App predicts risk of developing Alzheimer’s

A new study from Lund University in Sweden shows that validated biomarkers can reveal an individual’s risk of developing Alzheimer’s disease. Using a model that combines the levels of two specific proteins in the blood of those with mild memory impairment, the researchers are able to predict the risk of developing Alzheimer’s. The researchers have also developed an app that doctors can use to give

https://www.multipark.lu.se/article/app-predicts-risk-developing-alzheimers - 2025-12-15

SWEBAGS launched!

The Swedish Basal Ganglia Society We are happy to announce the formation of SWEBAGS - the Swedish Basal Ganglia Society. SWEBAGS is a nationwide non-profit organization providing a platform for scientific discussion and education in basal ganglia-related research. We aim to foster multidisciplinary collaborations across biological scales and methodological approaches. All professionals, students a

https://www.multipark.lu.se/article/swebags-launched - 2025-12-15

TNU:s research selected for oral presentation at the EHDN meeting

Dr Rana Soylu Kucharz presented her recent project with the title "Striatal Neuropathology induced by Hypothalamic Overexpression of Huntingtin Fragments using Adeno-associated Viral Vectors in Mice” as an oral presentation in the Short Communication session at the EHDN meeting in the Hague, the Netherlands, in September 2016.

https://www.huntington-research.lu.se/article/tnus-research-selected-oral-presentation-ehdn-meeting - 2025-12-15

A Huntingtoncenter has been formed at Lund University and Region Skåne headed by Professor Åsa Petersén

A new initiative between Lund University and Region Skåne is the formation of an excellence center for Huntington disease. The aim is to bring research closer to the clinic and to provide multidisciplinary care by experts for families with HD at all stages.The center will work in close collaboration with industry and patient organizations. The center is headed by Professor Åsa Petersén. See press

https://www.huntington-research.lu.se/article/huntingtoncenter-has-been-formed-lund-university-and-region-skane-headed-professor-asa-petersen - 2025-12-15

Dr Soylu-Kucharz receives Best Thesis in 2016 award

Dr Rana Soylu Kucharz has received the Best Neurobiology section thesis 2016 award at EMV, Lund University.Congratulations!!!   Best Neurobiology section PhD thesis 2016 Best Neurobiology section PhD thesis 2016 was awarded Dr. Rana Soylu Kucharz for her thesis Hypothalamic and Metabolic Dysfunction in Genetic Models of Huntington's Disease.

https://www.huntington-research.lu.se/article/dr-soylu-kucharz-receives-best-thesis-2016-award - 2025-12-15

Sanaz Gabery - Hjärnfonden Stipendee

Dr Sanaz Gabery is one of 14 to receive Hjärnfonden's (Brain Foundation) stipend for postdoctoral researchers during 2019. Her project is focusing on white matter alterations in Huntington's disease. Earlier research has shown that grey matter is reduced in Huntington patients’ brains, which can be one explanation to these patients’ motor symptoms. Recent neuroimaging studies have shown that chang

https://www.huntington-research.lu.se/article/sanaz-gabery-hjarnfonden-stipendee - 2025-12-15

Huntington's disease information evening

Huntington Center is hosting this year's first information meeting in Lund on Huntington's disease on May 28. The evening is open for families with Huntington's disease and health care professionals. The Huntington team from the Neurology clinic at Skåne University Hospital will be present, as well as researchers from Lund University and the patients' organization RHS. There will be opportunity to

https://www.huntington-research.lu.se/article/huntingtons-disease-information-evening - 2025-12-15